cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome PMC Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




